-
平臺編號：bio-69029
-
國際編號：CRL-2737?
-
細(xì)胞信息： 132-1C8
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
132-1C8
數(shù)量：大量
生長狀態(tài)：懸浮生長
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG1 kappa
是否是腫瘤細(xì)胞：0
物種來源：小鼠
年限：adult
品系：129GIX+
ATCC Number：CRL-2737?
運(yùn)輸方式：凍存運(yùn)輸
器官來源：脾
規(guī)格：0.5mg Designations: 132-1C8
Depositors: ?National Cancer Institute
Isotype: IgG1 kappa
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Organ: spleen
Strain: 129GIX+
Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against a synthetic MYB oncogene peptide
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: adult
Gender: male
Comments:Animals were immunized with a synthetic polypeptide with the sequence RHYDEDPEKEKRIKELEL corresponding to peptides 282 to 300 of the MYB oncogene. Spleen cells were fused with Sp2/0 myeloma cells. The antibody reacts with the synthetic MYB oncogene peptide. In immunoblot assays, the antibody recognizes proteins of approximately 80 kd and 60 kd in extracts from MSTF cells (mink lung cells transformed by fes). In human tumor (MOLT 4), a 60 kd protein is detected as well as two proteins of 40 and 45 kd. These two proteins of 40 and 45 kd are also detected in human brain extracts. In BM2 cells, proteins of 50 kd and 20 kd are detected.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10(5) viable cells/ml.
Interval: Maintain cell density between 1 X 10(5) and 1 X 10(6) viable cells/ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSOComplete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
生長狀態(tài)：懸浮生長
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG1 kappa
是否是腫瘤細(xì)胞：0
物種來源：小鼠
年限：adult
品系：129GIX+
ATCC Number：CRL-2737?
運(yùn)輸方式：凍存運(yùn)輸
器官來源：脾
規(guī)格：0.5mg Designations: 132-1C8
Depositors: ?National Cancer Institute
Isotype: IgG1 kappa
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Organ: spleen
Strain: 129GIX+
Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against a synthetic MYB oncogene peptide
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: adult
Gender: male
Comments:Animals were immunized with a synthetic polypeptide with the sequence RHYDEDPEKEKRIKELEL corresponding to peptides 282 to 300 of the MYB oncogene. Spleen cells were fused with Sp2/0 myeloma cells. The antibody reacts with the synthetic MYB oncogene peptide. In immunoblot assays, the antibody recognizes proteins of approximately 80 kd and 60 kd in extracts from MSTF cells (mink lung cells transformed by fes). In human tumor (MOLT 4), a 60 kd protein is detected as well as two proteins of 40 and 45 kd. These two proteins of 40 and 45 kd are also detected in human brain extracts. In BM2 cells, proteins of 50 kd and 20 kd are detected.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10(5) viable cells/ml.
Interval: Maintain cell density between 1 X 10(5) and 1 X 10(6) viable cells/ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSOComplete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
